![](/img/cover-not-exists.png)
Her2/neu-positive disease does not increase risk of locoregional recurrence for patients treated with neoadjuvant doxorubicin-based chemotherapy, mastectomy, and radiotherapy
Thomas A Buchholz, Eugene H Huang, Donald Berry, Lajos Pusztai, Eric A Strom, Marsha D McNeese, George H Perkins, Naomi R Schechter, Henry M Kuerer, Aman U Buzdar, Vicente Valero, Kelly K Hunt, GabrieVolume:
59
Year:
2004
Language:
english
Pages:
6
DOI:
10.1016/j.ijrobp.2004.02.018
File:
PDF, 80 KB
english, 2004